SCHEMBL9107797

SCHEMBL9107797

CCCCCCCCO[Si](C)(C)O[Si](C)(C)O[Si](C)(C)OCCCCCCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CES2 O00748 1/20 0.39
TSHR P16473 1/20 0.38
USP2 O75604 1/20 0.36
LPAR3 Q9UBY5 6/20 0.35
CA1 P00915 6/20 0.35
CA2 P00918 6/20 0.35
CA9 Q16790 6/20 0.35
LPAR2 Q9HBW0 5/20 0.35
LPAR1 Q92633 2/20 0.35
CA12 O43570 2/20 0.35
CA3 P07451 2/20 0.35
CA4 P22748 2/20 0.35
CA6 P23280 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2918409 1.00 THRB (0.41) THRBMEN1HTTKMT2AMAPT
SCHEMBL2913295 1.00 THRB (0.41) THRBMEN1HTTKMT2AMAPT
SCHEMBL2922320 0.98 THRB (0.43) THRBMEN1HTTKMT2AMAPT
SCHEMBL27090158 0.98 THRB (0.43) THRBMEN1HTTKMT2AMAPT
SCHEMBL8805375 0.95 THRB (0.39) THRBMEN1HTTKMT2AMAPT
SCHEMBL28256027 0.94 THRB (0.38) THRBMEN1HTTKMT2AMAPT
SCHEMBL26676555 0.88 THRB (0.36) THRBMEN1HTTKMT2AMAPT
SCHEMBL28961491 0.87 LPAR3 (0.44) THRBMEN1HTTKMT2AMAPT
SCHEMBL2950261 0.87 TSHR (0.40) THRBMEN1HTTKMT2AMAPT
SCHEMBL10880322 0.87 LPAR3 (0.44) THRBMEN1HTTKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142956-A1 PROCESS FOR REACTING HYDROXYL COMPOUNDS WITH LINEAR, BRANCHED OR CYCLIC POLYALKYLSILOXANES EVONIK GOLDSCHMIDT GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142956-A1 PROCESS FOR REACTING HYDROXYL COMPOUNDS WITH LINEAR, BRANCHED OR CYCLIC POLYALKYLSILOXANES HAO2, MSR1, OR10J3 THRB 1552/4885MEN1 2375/4885HTT 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.